GVR Report cover Transplantation Market Size, Share, & Trends Report

Transplantation Market Size, Share, & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-864-0
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Report Overview

The global transplantation market size was estimated at USD 12.4 billion in 2021 and is anticipated to expand at a CAGR of 9.4% during the forecast period. Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the market growth. Organ failure usually occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. Demand for tissue and organ transplantation, mainly kidney, heart, liver, and lungs, is very high globally. Unhealthy dietary habits, alcohol consumption, lack of exercise, and drug abuse are some leading causes of organ failure. Thus, demand for transplantation products is expected to rise in the near future.

 India transplantation market size, by product, 2020 - 2030 (USD Million)

After a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases as their immunity is weakened. This can be attributed to the decline in transplantation numbers in many countries amid the COVID-19 situation. Moreover, the shortage of resources such as primary protective equipment, ICU, and blood products during the pandemic has contributed to the sharp fall in the market’s revenue in 2021.     

The global increase in the demand for organs for transplant can be attributed to an increase in the incidence of acute diseases, which in turn results in an increase in the number of organ failures. For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, where kidney transplants or dialysis are the only treatment options to keep a patient alive. According to the U.S. Department of Health & Human Services, there were around 122,913 patients in the U.S. waiting to receive organs for transplant in 2019. Thus, there are high demand for advanced transplantation products for the treatment of organ failure.

Some of the major driving factors impacting the market include the introduction of technologically advanced products and an increasing number of tissue banks. However, some of the factors such as the shortage of organ donors for transplantation procedures are expected to restrain the market growth. There is a huge gap between the demand and supply of organs for organ failure treatment. According to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients waiting for kidney transplants in the U.S. However, only 23,401 kidney transplant procedures were performed in 2019. Lack of awareness for organ donation and religious & customary beliefs prevent a large number of people from donating. Thus, the shortage of organs for the treatment of organ failure is expected to adversely affect the market growth.

Product Insight

Tissue products were the highest revenue-generating segment in 2021 with a market share of 57.8%. Major products used for tissue or organ transplantation are tissue products, immunosuppressants, and preservation solutions. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow, and orthopedic soft tissues is attributed to the growth of the segment. In addition, new product development is also fueling market growth.

For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, a new orthobiologic product that is intended for use in capsular reconstruction. This product allows retention of its growth factors and native collagen scaffold and elastin and allows transplant to be successfully incorporated into the receiver.

Manufacturers are focusing on new product development, mergers & acquisition, and collaborations to expand their current product portfolio and reinforce their position in the industry. For instance, in September 2016, Stryker Corporation announced the acquisition of Instratek, a leading manufacturer of minimally invasive soft tissue recession instruments for ankle, foot, and upper extremity procedures.

Immunosuppressive drugs segment is projected to showcase lucrative growth during the study period. This can be attributed to the high usage of these drugs to prevent post-transplant tissue or organ rejection. The increasing prevalence of chronic diseases has led to a rise in demand for organ replacement globally. Thus, demand for immunosuppressive drugs is expected to rise at a significant pace during the forecast period.

The preservation solutions segment is expected to exhibit significant growth during the study period due to rising government support for stem cell research and the high application of these products to improve the physiological function of organs. In addition, rising cases of organ failure, increasing organ transplant procedures, and escalating number of organ donations worldwide are expected to drive the segment growth.

Application Insight

Tissue transplantation dominates the market with market size of 7.6 billion in 2021. This is due to the fact that the replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are most commonly performed procedure worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products. According to the European Road Safety Observatory report, there were 102,362 injury accidents were reported in Spain. Thus, creating the demand for tissue transplantation.

The organ transplantation segment is expected to show a lucrative growth rate during the forecast period. The increasing number of organ transplantations globally as well as the repetitive purchase of immunosuppressants is anticipated to boost the market growth in the near future. For instance, in 2017, around 90,306 kidney transplant procedures were performed globally.

Advancement in transplantation technology and the launch of new products by manufacturers is expected to propel the number of transplant procedures, including kidney, liver, heart, lungs, and tissues. For instance, in November 2020, Lupin announced the launch of the generic immunosuppressant drug Tacrolimus in the U.S. market indicated for prophylaxis of organ rejection in the allogeneic liver, kidney, and heart transplant.

 Global Transplantation Market share, by application, 2021 (%)

In 2020, a high number of transplant procedures was documented in the U.S., Germany, U.K., and France, and this number is expected to increase in the near future. Thus, there is high demand for transplantation products in these countries. Well-developed healthcare infrastructure and availability of expert surgeons & advanced products in these countries are some key factors that can be attributed to the growth of the regional market

End-Use Insight

The hospitals segment held the largest market share of 49.6% in the year 2021. A large number of organ and tissue transplant procedures are conducted at hospitals as they are primary treatment centers. Additionally, the emergence of hospitals with developed infrastructure is further expected to fuel market growth. Majority of these hospitals have access to well-defined databases to check for the availability of organs aiding in rapid medical intervention

The number of transplant centers is expected to exhibit the highest growth during the forecast period. Escalating transplantation procedures have triggered the need for an increased number of healthcare centers catering to the unmet needs of the patients. Also, rising government initiatives to encourage organ donation are projected to propel market growth. For instance, the Health Resources and Services Administration's Division of Transplantation sponsored four grant programs that focus on increasing the number of organs donors and transplant procedures.

As a result of established healthcare infrastructure in the U.S., France, U.K., and other European countries, demand for advanced transplant products for the management of organ failure & tissue replacement has increased. Moreover, the number of advanced transplant centers in these regions is increasing. For instance, according to the National Kidney Center, there are around 244 kidney transplant centers in the U.S.Rising number of organ donors and improving healthcare infrastructure in developing economies such as China, India, Argentina, and Brazil are expected to propel market growth. In addition, demand for these products in these countries is rising due to the growing burden of acute and chronic diseases, such as high blood pressure and diabetes.

Regional Insights

In 2021, North America dominated the transplantation market with a market share of 39.4% and is expected to maintain its dominance throughout the study period. Well-developed healthcare facilities and the local presence of many large biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker are supporting the market growth.

The gap between demand and supply of organs, including kidneys, liver, and heart, for transplantation, has increased in the last decade. However, governments and NGOs of various countries are taking initiatives to encourage people to donate organs and save lives. New guidelines and rules for organ donation make the donation process more transparent and easier. In 2020, the Human Resource & Services Administration launched the Hospital Organ Donor Campaign in April 2020. This led to an increase in the number of organ donations from the previous year.

Asia Pacific market is projected to rise at the highest rate during the forecast period, owing to the growing research on stem cells to develop in-vitro tissue and organs as well as developing healthcare infrastructure in Asian countries such as India, Thailand, Philippines, Indonesia.

Key Companies & Market Share Insights

The market is highly fragmented with the presence of many large, small, and medium-scale vendors. The leading players in the industry are, such as Zimmer Biomet; Medtronic; Stryker Corporation. These players are involved in launching new products, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, in May 2020, AbbVie announced the acquisition of Allergan to strengthen its product portfolio and distribution channels.

Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting, have led to high demand for transplant products. This 3D bioprinting can be used to regenerate tissues and organs. For instance, in September 2020 Israel-based CollPlant Biotechnologies and United therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant. Some of the prominent players in the transplantation market include.

  • Abbvie, Inc

  • Arthrex, Inc.

  • Zimmer Biomet

  • Medtronic

  • Novartis AG

  • Strykers

  • 21st Century Medicine

  • BiolifeSolutions, Inc

  • Teva Pharmaceuticals

  • Veloxis Pharmaceutical

Transplantation Market Report Scope

            Report Attribute

                                    Details

Market size value in 2022

USD 15.05 billion

Revenue forecast in 2030

USD 30.9 billion

Growth rate

CAGR of 9.4% from 2022 to 2030

Base year for estimation

2021

Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion, Volume, Units and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, end-use, region

Regional scope

North America, Europe, Asia Pacific, Latin America, and MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; Japan; India; Mexico; Brazil; South Africa; Saudi Arabia

Key companies profiled

AbbVie, Inc.; Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; Stryker; 21st Century Medicine; BioLifeSolutions, Inc; Teva Pharmaceuticals; and Veloxis Pharmaceuticals

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized options to meet your exact research needs. Explore purchase options

 

Segments covered in the report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on industry trends in each sub-segment from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global transplantation market on the basis of product, application, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2018 - 2030)

    • Tissue Products

    • Immunosuppressive Drugs

    • Preservation Solution

  • Application Outlook (Revenue, USD Billion; 2018 - 2030)

    • Organ Transplantation

    • Tissue Transplantation

  • End-Use Outlook (Revenue, Usd Billion; 2018 - 2030)

    • Hospitals

    • Transplant Centers

    • Others

  • Regional Outlook (Revenue, USD Billion; 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon